Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Buy Star Health; target of Rs 640: Motilal Oswal
Motilal Oswal is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 640 in its research report dated April 29, 2026.
Taking Stock: Market recovers but Nifty ends below 24,000; Sensex falls 583 pts
More than 100 stocks touched their 52-week high on the BSE, including Himadri Speciality, HFCL, Sai Life Sciences, Coal India, Hitachi Energy, Navin Fluorine, ONGC, Apar Industries, MCX India, Lloyds Metals, Chennai Petro, among others.
Buy Niva Bupa Health Insurance; target of Rs 100: Motilal Oswal
Motilal Oswal recommended is bullish on Niva Bupa Health Insurance recommended buy rating on the stock with a target price of Rs 100 in its research report dated Jun 19, 2026.
Max Healthcare shares fall up to 7% as Q4 results miss estimates
Analysts at domestic brokerage Motilal Oswal Financial Services said the earnings miss was due to a higher tax rate .
Neutral Indegene; target of Rs 552: Motilal Oswal
Motilal Oswal recommended Neutral rating on Indegene with a target price of Rs 552 in its research report dated May 02, 2026.
Neutral Zydus LifeSciences; target of Rs 1080: Motilal Oswal
Motilal Oswal recommended Neutral rating on Zydus LifeSciences with a target price of Rs 1080 in its research report dated May 20, 2026.
Buy Laurus Labs; target of Rs 1370: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 1370 in its research report dated April 30, 2026.
Buy Five Star Business Finance; target of Rs 600: Motilal Oswal
Motilal Oswal recommended is bullish on Five Star Business Finance recommended buy rating on the stock with a target price of Rs 600 in its research report dated Jun 22, 2026.
Buy Ajanta Pharma; target of Rs 3400: Motilal Oswal
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated May 05, 2026.
Buy Laurus Labs; target of Rs 1280: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated February 25, 2026.
Markets Erase Gains! Sensex, Nifty See Sharp Pullback | Closing Bell
Indian equity markets turned volatile with the Sensex tumbling over 400 points from the day’s high and the Nifty slipping nearly 100 points. Broader markets remained mixed as smallcaps saw selling pressure. While Realty and FMCG stocks stayed under stress, the Nifty Pharma index extended gains for the fifth straight session. IT stocks also attracted buying interest for the second consecutive day. Catch Lovisha Darad in conversation with market expert Anshul Saigal and Nilesh Jain, Head VP – Derivative and Technical Research at Centrum Broking Ltd, for detailed market insights and strategy.
Neutral Blue Star; target of Rs 1920: Motilal Oswal
Motilal Oswal recommended Neutral rating on Blue Star with a target price of Rs 1920 in its research report dated May 07, 2026.